ReproCell Of Japan Searches For Niche As Regenerative Medicine
This article was originally published in PharmAsia News
Japan's ReproCell, which claims to be a pioneer in regenerative medicine, is among research companies trying to find practical applications for their work
You may also be interested in...
The company said its own calculations suggest a mid-November readout could yield a positive result, keeping it on track for an EUA before the end of 2020.
With COVID-19 continuing to wreak havoc in the EU just as throughout the globe, the European Commission is proposing new measures that will impact antigen test availability and use
Amgen’s management took a deep dive into biosimilar market dynamics during the company’s third-quarter earnings call, as the California-based biotech continued to enjoy success for biosimilars in the US and Europe.